News Detail

Argos Therapeutics Presents Positive Phase 2 Viral Load and Immune Response Data for Arcelis™ HIV Program at the AIDS Vaccine 2009

21 Oct 2009

by:

Read the article

MedVantx Subsidiary Announces Contract Award By the Montana Association of Health Care Purchasers | TRANSMOLECULAR’S 131I-TM601 SHOWN TO IMPROVE SURVIVAL IN RECURRENT MALIGNANT GLIOMA